SOLVAY 1220 (Creon 20 66,400 units amylase; 20,000 units lipase; 75,000 units protease)

Generic Name: pancrelipase

Pill imprint SOLVAY 1220 has been identified as Creon 20 66,400 units amylase; 20,000 units lipase; 75,000 units protease.

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 66,400 units amylase; 20,000 units lipase; 75,000 units protease is not subject to the Controlled Substances Act.

See also related documents.

Images for SOLVAY 1220 (Creon 20 66,400 units amylase; 20,000 units lipase; 75,000 units protease)

Creon 20 66,400 units amylase; 20,000 units lipase; 75,000 units protease SOLVAY 1220
Creon 20
Generic Name:
pancrelipase
Imprint:
SOLVAY
1220
Strength:
66,400 units amylase; 20,000 units lipase; 75,000 units protease
Color:
Orange / Clear
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Solvay Pharmaceuticals Inc.
National Drug Code (NDC):
00032-1220
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-3475 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web2)